712 results about "Aryl radical" patented technology

The invention provides substituted diaryl compounds as shown in general formula (I) or their pharmaceutically acceptable salts, and also provides a preparation method; a class of novel broad-spectrum antiviral compounds and pharmaceutical salts targeting cytokines are screened and obtained through studies on structure-activity relationship and action mechanism of active compounds; the compounds not only have significant broad-spectrum antiviral activity, but also have the advantages of low toxicity and good pharmaceutical properties.

A method is provided for treating androgen receptor-associated conditions such as age-related diseases, for example sarcopenia, employing a compound of the structure

wherein

• • R₁ is CN or H; X is O or S;
  • R₂ is alkyl or substituted alkyl, cycloalkyl or substituted cycloalkyl, arylalkyl or substituted arylalkyl, aryl or substituted aryl, or heteroaryl or substituted heteroaryl;
  • R₃ and R₄ are the same or different and are independently selected from H, C(O)R_2a, alkyl or substituted alkyl, cycloalkyl or substituted cycloalkyl, arylalkyl or substituted arylalkyl, aryl or substituted aryl, or heteroaryl or substituted heteroaryl;
  • R_2a is alkyl or substituted alkyl, cycloalkyl or substituted cycloalkyl, arylalkyl or substituted arylalkyl, aryl or substituted aryl, or heteroaryl or substituted heteroaryl;
  • G is aryl or heteroaryl, or aryl or heteroaryl substituted with one, two, three, four or five, where possible, of the substituents selected from the group consisting of hydrogen (H), halo, NO₂, CN, OR_2b, OH, CF₃, NR_3aR_4a;
  • wherein R_3a and R_4a, and R_2b are the same or different and are independently selected from alkyl or substituted alkyl, cycloalkyl or substituted cycloalkyl, arylalkyl or substituted arylalkyl, aryl or substituted aryl, or heteroaryl and substituted heteroaryl; or a pharmaceutically acceptable salt thereof and a prodrug ester thereof.

Provided are an anthracene derivative having a heteroaryl group containing a nitrogen-containing six-membered ring and having a specific structure and an organic electroluminescence device in which an organic thin film layer comprising a single layer or plural layers including at least a light emitting layer is interposed between a cathode and an anode, wherein at least one layer in the above organic thin film layer contains the anthracene derivative described above in the form of a single component or a mixed component. Provided are the organic electroluminescence device in which homogeneous light emission is obtained over a long period of time and which has a long lifetime and the anthracene derivative which materializes the same.

Compounds, compositions and methods that are useful for the treatment of metabolic disorders, inflammatory diseases and cancer are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in lipid metabolism, inflammation and cell proliferation. The subject compounds are linked biaryl compounds.

Methods are disclosed of making linear and cross-linked, HMW (high molecular weight) polysilanes and polygermanes, polyperhydrosilanes and polyperhydrogermanes, functional liquids containing the same, and methods of using the liquids in a range of desirable applications. The silane and germane polymers are generally composed of chains of Si and/or Ge substituted with R′ substituents, where each instance of R′ is, for example, independently hydrogen, halogen, alkenyl, alkynyl, hydrocarbyl, aromatic hydrocarbyl, heterocyclic aromatic hydrocarbyl, SiR″₃, GeR″₃, PR″₂, OR″, NR″₂, or SR″; where each instance of R″ is independently hydrogen or hydrocarbyl. The cross-linked polymers can be synthesized by dehalogenative coupling or dehydrocoupling. The linear polymers can be synthesized by ring-opening polymerization. The polymers can be further modified by halogenation and/or reaction with the source of hydride to furnish perhydrosilane and perhydrogermane polymers, which are used in liquid ink formulations. The synthesis allows for tuning of the liquid properties (e.g., viscosity, volatility, and surface tension). The liquids can be used for deposition of films and bodies by spincoating, inkjetting, dropcasting, etc., with or without the use of UV irradiation. The deposited films can be converted into amorphous and polycrystalline silicon or germanium, and silicon or germanium oxide or nitride by curing at 400-600 DEG C. and (optionally) laser- or heat-induced crystallization (and/or dopant activation, when dopant is present).

A polymer comprising recurring units of a sulfonium salt represented by formula (1) is provided as well as a chemically amplified resist composition comprising the same. R¹ is H, F, methyl or trifluoromethyl, R² to R⁴ are C₁-C₁₀ alkyl or alkoxy, R⁵ is C₁-C₃₀ alkyl or C₆-C₁₄ aryl, k, m and n are 0 to 3. The recurring units generate a sulfonic acid upon exposure to high-energy radiation so as to facilitate effective scission of acid labile groups in the resist composition. The resist composition exhibits excellent resolution and a pattern finish with minimal LER.

The invention discloses a C3/C3 fluoroquinolone dimmer derivative using oxadiazole as a connection chain as well as a preparation method and an application thereof. The C3/C3 fluoroquinolone dimmer derivative using oxadiazole as a connection chain is a compound which has the following structural general formula (I), wherein R1 and R1' are independently selected from H, (C1-C10) alkyl, (C3)-(C10) cycloalkyl, (C1)-(C10) haloalkyl and substituted aryl group or substituted heterocyclic aryl group; R2 and R2' are independently selected from H, (C1-C7)alkyl, (C3)-(C7) cycloalkyl, substituted aryl group, substituted heterocyclic aryl group and hydrocarbon acyl or sulfonyl; R3 and R3' are independently selected from H, (C1-C5) alkyl, (C3)-(C5) cycloalkyl, substituted aryl radical or substitutionalheterocyclic aryl radical; and X and Y are independently selected from CH, N or carbon atoms connected with halogen, alkyl, oxyl, sulfenyl, amino, substituted amino, substituted aryl radical or substituted heterocyclic aryl radical. The C3/C3 fluoroquinolone dimmer derivative using oxadiazole as a connection chain can be used for preparing medicaments for treating tumors and preventing microbialinfection diseases.

Azole compounds represented by formula I: wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.

The present invention relates to reactive compositions containing A) one or more blocked polyurethane prepolymers which have a content of blocked isocyanate groups (calculated as NCO) of 0.1 to 20 wt. % and are prepared from i) at least one aromatic, aliphatic, araliphatic and/or cycloaliphatic diisocyanate having a content of free NCO groups of 5 to 60 wt. %, ii) a polyol component containing at least one polyester polyol, and/or at least one polyether polyol and/or at least one polycarbonate polyol,

iii) CH-acidic cyclic ketones corresponding to formula (I) as blocking agents

wherein X represents an electron-attracting group,

• R¹ and R² independently of one another represent the radicals H,
• C₁-C₂₀ (cyclo)alkyl, C₆-C₂₄ aryl, C₁-C₂₀ (cyclo)alkyl ester or amide, C₆-C₂₄ aryl ester or amide, mixed aliphatic/aromatic radicals with 1 to 24 carbon atoms that can also be part of a 4- to 8-membered ring, n is an integer from 0 to 5, and B) one or more OH-functional compounds in which the OH component undergoes activation by a deposition amine component. The present invention also relates to a composite system containing two adherends bonded together with the reactive composition according to the invention.

Disclosed herein is an injectable long-acting analgesic composition comprising:

(a) a ketorolac ester derivative of formula (I),  wherein

• •  R is a straight-chain or branched saturated or unsaturated C₁-C₂₀ aliphatic group optionally substituted with a C₆-C₁₀ aryl group; and (b) a pharmaceutically acceptable oil vehicle. The composition can provide a longer duration of action and, therefore, is suitable for use in the treatment of long-lasting pains and inflammations.

Sulfonate salts have the formula: R¹COOCH₂CH₂CF₂CF₂SO₃⁻M⁺ wherein R¹ is alkyl, aryl or hetero-aryl, M⁺ is a Li, Na, K, ammonium or tetramethylammonium ion. Onium salts, oxime sulfonates and sulfonyloxyimides derived from these salts are effective photoacid generators in chemically amplified resist compositions.

The present invention relates to a compound of the formula

wherein R¹ is substituted aryl, heteroaryl and the like, R² and R³ are hydrogen, alkyl, halogen, hydroxyl group and the like, Q is N, CH and the like, W is hydrogen, alkyl, hydroxycarbonylalkyl and the like, X is halogen, cyano, nitro, amino and the like, X′ is hydrogen, halogen, cyano, nitro, and Y is alkyl, hydroxyl group, alkoxy, mercapto and the like and a salt thereof, and a medicine containing the said compound. The compound of the present invention shows a superior inhibitory effect on activated lymphocytes proliferation and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.

A thermoplastic composition includes a poly(arylene ether) and a poly(arylene ether)-polysiloxane block copolymer. The thermoplastic composition is prepared by a method that includes oxidatively copolymerizing a monohydric phenol and a hydroxyaryl-terminated polysiloxane. The method is simpler than prior methods of preparing poly(arylene ether)-polysiloxane block copolymers by linking pre-formed poly(arylene ether) and polysiloxane blocks. The method is also produces greater incorporation of polysiloxane into the poly(arylene ether)-polysiloxane block copolymer than prior methods of copolymerizing monohydric phenols and hydroxyaryl-terminated polysiloxane.

Process for the gas-phase polymerization of olefins of the formula CH2=CHR where R is hydrogen or an alkyl or aryl radical with 1 to 8 carbon atoms carried out in one or more reactors having a fluidized or mechanically agitated bed, using a catalyst obtained by reaction of a titanium halide or haloalcoholate and optionally an electron-donor compound supported on an active Mg-dihalide with an Al-trialkyl compound and optionally an electron-donor compound, comprising the steps of:a) contacting the catalyst components in the absence of polymerizable olefin or optionally in the presence of said olefin in an amount to from up to 3 g per g of solid catalyst component;b) prepolymerizing propylene or mixtures of propylene with ethylene or an alpha-olefin to form a propylene polymer having an insolubility in xylene of at least 60% by weight, in an amount of from 5 g of polymer per g of solid catalyst component to 10% by weight of the final catalyst yield; andc) polymerizing one or more CH2=CHR olefins in the gas phase in the presence of the prepolymer-catalyst system obtained in b), while maintaining in the gas phase an alkane in a molar concentration with respect to the total gases of from 20 to 90%.

Disclosed is a fluorinated sulfonic acid salt or fluorinated sulfonic acid group-containing compound having a structure represented by the following general formula (A).

In the formula, n indicates an integer of 1 to 10; R indicates a substituted or unsubstituted C₁-C₂₀ linear, branched or cyclic alkyl group, a substituted or unsubstituted C₁-C₂₀ linear, branched or cyclic alkenyl group, a substituted or unsubstituted C₆-C₁₅ aryl group, or a C₄-C₁₅ heteroaryl group; and a indicates 1 or 0. A photoacid generator containing the above fluorinated sulfonic acid salt or fluorinated sulfonic acid group-containing compound shows high sensitivity to an ArF excimer laser or the like, presents no concerns about human body accumulation, can generate an acid (photoacid) of sufficiently high acidity, and exhibits high solubility in a resist solvent and good compatibility with a resist resin.

The present invention relates to an amino-functional polysiloxane of formula (1) where each R¹ is independently selected from alkyl or aryl radicals, each R² is independently selected from hydrogen, alkyl or aryl radicals, n is selected so that the molecular weight for the functional polysiloxane is in the range of from 400 to 10,000 and R³ is a bivalent radical or —O—R³—NH—R⁵ is hydroxy or alkoxy, and R⁵ is selected from hydrogen, aminoalkyl, aminoalkenyl, aminoaryl, aminocycloalkyl radical, optionally substituted by alkyl, aryl, cycloalkyl, halogen, hydroxy, alkoxy, thioalkyl, amino, amino derivatives, amido, amidoxy, nitro, cyano, keto, acyl derivatives, acyloxy derivatives, carboxy, ester, ether, esteroxy, heterocycle, alkenyl or alkynyl and where 0 to 90% of —O—R³—NH—R⁵ is hydroxy or alkoxy. The present invention further relates to an epoxy-polysiloxane composition which includes an aminopolysiloxane hardener component or an amino-functional polysiloxane hardener component of formula (1), having active hydrogens able to react with epoxy groups in an epoxy resin to form epoxy polymers, and able to react with a polysiloxane to form polysiloxane polymers, wherein the epoxy chain polymers and polysiloxane polymers polymerize to form a cured epoxy-polysiloxane polymer composition.

Polycarbonates incorporating terminal carbonate groups derived from ester-substituted activated carbonates, for example terminal methyl salicyl carbonate (TMSC) derived from the use of BMSC as the activated carbonate in a transesterification process, have unfavorable properties with respect to color, hydrolytic stability and thermal stability, particularly when the polycarbonate containing such end groups is molded. The number of activated carbonate end groups formed during the melt transesterification formation of polycarbonate can be reduced, however, without sacrificing the benefits of using an activated diaryl carbonate, and without requiring a separate reaction or additional additives by reacting a dihydroxy compound with an activated diaryl carbonate in the presence of an esterification catalyst to produce a polycarbonate, wherein the molar ratio of activated diaryl carbonate to dihydroxy compound is less than 1 when expressed to at least three decimal places, for example 0.996 or less.

The present invention provides one kind of catalyst for polymerization of olefin and the catalyst includes Mg, Ti, halogen and electron donor. The electron donor is at least one kind of dialcohol ester compound.

The invention relates to the use of compounds of the formula (1)

in which

• R¹ is C₁- to C₂₄-alkyl, C₂- to C₂₄-alkenyl or a C₆- to C₁₈-aryl radical which may be substituted by a C₁- to C₂₄-alkyl group,
• R², R³ independently of one another, are hydrogen, C₁- to C₁₈-alkyl, or C₈- to C₇-cycloalkyl, or R² and R³, including the nitrogen atom to which they are bonded, form a ring of 4 to 8 ring atoms, in which oxygen or nitrogen atoms may also be present in addition to carbon.
• A are identical or different C₂- to C₄-alkylene radicals,
• B is C₁- to C₇-alkylene, and
• n is an integer from 1-40,

as gas hydrate inhibitors.

The present invention relates to a process for lowering the viscosity of compositions containing compounds having urethane groups, in which all or some of the urethane groups contained therein are reacted with monoisocyanates to form allophanate groups. The present invention also relates to compounds having allophanate groups and compositions containing such compounds, wherein at least 10 mole % of the allophanate groups contained therein correspond to formula I)

wherein R is an alkyl, aralkyl or aryl radical which has up to 20 carbon atoms and optionally contains heteroatoms and wherein these radicals can also have, in addition to the NCO group present as part of the allophanate group, other functional groups which are neither isocyanate groups nor functional groups derived from isocyanate groups.